p8

Cambridge Healthtech Institute’s 12th Annual

Engineering Genes, Vectors, Constructs, and Clones

January 20-21, 2020

Part of the Biotherapeutic Expression & Production pipeline

 

The demand for high-quality biotherapeutic proteins has never been greater. Many variables still must be considered during the cell-line development process, including verification and sequence analysis of the gene or protein of interest, codon optimization, vector construction, and clone/host selection – a time-consuming and expensive process. Additionally, protein expression scientists are now exploring new engineering tools, such as synthetic biology and systems engineering. Ultimately, these tools must be weighed against traditional expression and production strategies to achieve the desired quantity and quality.

Cambridge Healthtech Institute’s 12th Annual Engineering Genes, Vectors, Constructs, and Clones conference continues the tradition of applying effective engineering strategies for protein expression and production research leading to functional biotherapeutic products. Learn from seasoned, savvy researchers as they share their real-world experiences, applications, and results.

 

Coverage will include, but is not limited to:

  • Targeting Genes
    • Synthetic Biology
    • CRISPR
    • rDNA Synthesis and Selection
    • Targeting RNA
    • Sequence Analysis
    • Gene Editing
    • Codon Optimization
  • Enhancing Expression
    • System Engineering
    • Transfection
    • Host Prioritization
    • Screening for High Producers
    • Screening for Functional Proteins
    • Data Analysis
  • Optimizing Clones
    • Library Construction
    • Sequence Verification
    • Vector/Host
  • Case Studies
    • Success Stories
    • Best Practices
    • Lessons Learned

 

* The program is subject to change without notice, due to unforeseen reason.







2020 Conferences & Training Seminars